The large volume parenteral (LVP) market has experienced significant growth in recent years, expanding from $12.52 billion in 2024 to an expected $13.57 billion in 2025, marking a compound annual growth rate (CAGR) of 8.3%. This growth can be attributed to the increasing prevalence of chronic diseases, growth in the aging population, rising demand for sterile pharmaceuticals, expansion of healthcare infrastructure, and the development of regulatory frameworks for pharmaceuticals.
Looking to the future, the large volume parenteral (LVP) market is projected to continue this strong growth trajectory. The market is expected to reach $19.46 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. Factors contributing to this forecasted growth include growing demand for biologics and biosimilars, rising healthcare expenditure, expansion of pharmaceutical outsourcing, increasing focus on personalized medicine, and globalization of pharmaceutical supply chains. Key trends expected for the forecast period include technological advancements, the integration of advanced technologies in pharmaceutical production, and the rise in 3D printing applications for pharmaceuticals.
Get Your Free Sample of The Global Large Volume Parenteral (LVP) Global Market Report 2024 Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=12195&type=smp
What Is Driving The Growth of the Large-Volume Parenteral Market?
One of the key factors driving the growth of the large-volume parenteral market is the growing prevalence of chronic diseases. Chronic diseases, which typically last three months or longer and can potentially worsen over time, are largely driven by tobacco use, exposure to smoke, and poor nutrition. Patients with these conditions often require appropriate nutrient dosage which is effectively facilitated by the parenteral mode of administration as it allows most of the drug to be directly absorbed into circulation, bypassing the digestive system. For instance, in September 2023, the World Health Organization reported that there were 41 million deaths annually globally due to non-communicable diseases (NCDs) or chronic diseases. This demonstrates the increasing prevalence of chronic diseases and the consequent drive for growth in the large-volume parenteral market.
What Are the Major Segments Within the Global Large Volume Parenteral (LVP) Market?
1) By Type: Soft Bag LVP, Plastic Bag LVP, Glass Bottle LVP
2) By Volume: 100 ML – 250 ML, 250 ML – 500 ML, 500 ML – 1000 ML, 1000 ML -2000 ML, 2000 And More
3) By Application: Basic Infusion, Therapeutics Infusion, Nutritious Infusion
4) By End-User: Hospital, Medical Centers, Other End Users
Order your report now for swift delivery: https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report
Which Key Players Are Operating In The Large Volume Parenteral (LVP) Market?
Major companies operating in the large volume parenteral (LVP) market include Pfizer Inc., Fresenius Kabi AG, Abbott Laboratories Inc., Becton Dickinson and Company, Otsuka Holdings Co Ltd., Baxter International Inc., B Braun Melsungen AG, Grifols SA, Cipla Limited, ICU Medical Inc., Biocon Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Alembic Pharmaceuticals Limited, Cadila Healthcare Ltd., Gland Pharma Limited, Akums Drugs & Pharmaceuticals Ltd., Beximco Pharmaceutical Ltd., Nelson Laboratories LLC, Taj Pharmaceuticals Limited, Albert David Ltd., Amanta Healthcare Ltd., Unique Pharmaceutical Laboratories Ltd., Ahlcon Parenterals India Ltd, Parenteral Drugs Limited, Abaris Healthcare Pvt. Ltd., BML Parenteral Drugs, Denis Chem Lab Ltd, Pentagon Labs Ltd., DJ Labs Pvt Ltd., Higgs Healthcare.
What Emerging Trends Are Impacting The Large Volume Parenteral (LVP) Market?
Product innovation has emerged as a significant trend within the large-volume parenteral market. Market leaders are focusing their efforts on creating innovative products to strengthen their market position. An example of this trend is demonstrated by SGD Pharma SA. This France-based producer of molded and tubular glass for pharmaceutical primary packaging launched sterile and ready for aseptic filling 100-ml type I molded glass vials in March 2022. This innovation assists in preventing vial scratches, supports visual examination of filled vials, and reduces quality control rejection chances.
Which Region Is Expected To Experience The Fastest Growth In The Large Volume Parenteral (LVP) Market?
North America held the largest share of the large volume parenteral (LVP) market in 2024. However, Asia-Pacific is anticipated to be the fastest-growing region during the forecast period. The regions covered in the large volume parenteral (LVP) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Large Volume Parenteral (LVP) Global Market Report 2024 Report 2025 Offer?
Large volume parenteral (LVP) refers to sterile intravenous solutions of a volume of 100 ml or more that are terminally sterilized by heat. They are used for intravenous infusions to administer hydration, nourishment, and medicine. The Large Volume Parenteral (LVP) Global Market Report 2024 research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Purchase the exclusive report now to unlock valuable market insights: https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12195
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead. Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
